Congenital Cardiac Defects, Council on Cardiovascular Disease in the Young, Drugs : A Statement for Healthcare Professionals From the Committee on Cardiovascular Monitoring of Children and Adolescents Receiving Psychotropic
暂无分享,去创建一个
D. Atkins | R. Barst | K. Taubert | R. Shaddy | H. Gutgesell | R. Ringel | R. Humes | W. Franklin | M. Buck
[1] B. Birmaher,et al. Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.
[2] M. Sanguinetti,et al. Molecular Genetic Insights into Cardiovascular Disease , 1996, Science.
[3] R. Thisted,et al. Resolved: cardiac arrhythmias make desipramine an unacceptable choice in children. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.
[4] R L Slaughter,et al. Recent Advances: the Cytochrome P450 Enzymes , 1995, The Annals of pharmacotherapy.
[5] N. Ryan,et al. Estimation of the association between desipramine and the risk for sudden death in 5- to 14-year-old children. , 1995, The Journal of clinical psychiatry.
[6] R. Baldessarini,et al. Electrocardiographic effects of desipramine and 2-hydroxydesipramine in children, adolescents, and adults treated with desipramine. , 1993, Journal of the American Academy of Child and Adolescent Psychiatry.
[7] S. Fletcher,et al. Prospective study of the electrocardiographic effects of imipramine in children. , 1993, The Journal of pediatrics.
[8] Y Chen,et al. Mechanism of the cardiotoxic actions of terfenadine. , 1993, JAMA.
[9] R. Baldessarini,et al. A double-blind placebo controlled study of desipramine in the treatment ADD: II. Serum drug levels and cardiovascular findings. , 1989, Journal of the American Academy of Child and Adolescent Psychiatry.
[10] J. Schroeder,et al. Cardiovascular effects of desipramine in children. , 1989, Journal of the American Academy of Child and Adolescent Psychiatry.
[11] D. Roden,et al. Clinical features and basic mechanisms of quinidine-induced arrhythmias. , 1986, Journal of the American College of Cardiology.
[12] C. Popper,et al. Sudden Death Putatively Related to Desipramine Treatment in Youth: A Fifth Case and a Review of Speculative Mechanisms , 1995 .
[13] K. Wagner,et al. Potential mechanism of desipramine-related sudden death in children. , 1993, Psychosomatics.
[14] D. Cohen,et al. Sudden death in children receiving Norpramin: a review of three reported cases and commentary. , 1991, Journal of the American Academy of Child and Adolescent Psychiatry.
[15] G. Elliott,et al. Tricyclic Antidepressants: The QT Interval and Other Cardiovascular Parameters , 1990 .